VLX-101

N/A

Report date: 2025/05/07 14:45:46

Base Information

Drug NameVLX-101
Drug Alias NameVLX-101
ClassificationBiologics
Mechanisms of ActionSerum albumin binders
TargetsSerum albumin
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesValanx Biotech GmbH
China Registration ClassN/A

Develop Information

Active CompaniesValanx Biotech GmbH
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A